ethyl 3-methylthiopropionate

We are ethyl 3-methylthiopropionate CAS:13327-56-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:ethyl 3-methylthiopropionate
CAS.NO:13327-56-5
Synonyms:ethyl 3-methylthiopropionate
Ethyl 3-(Methylthio)propionate
ethyl 3-methylsulfanylpropanoate
3-(Methylthio)propionic Acid Ethyl Ester
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 200.5±23.0 °C at 760 mmHg
Molecular Formula C6H12O2S
Molecular Weight 148.223
Flash Point 81.0±10.6 °C
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Flavors and fragrances intermediate

ethyl 3-methylthiopropionate


Related News: There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.4-Fluoro-2-methylbenzonitrile Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.5925-75-7 In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.(2S)-1-Amino-3-chloro-2-propanol hydrochloride CAS:34839-13-9 In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.

Related Products
Product Name
4-Bromo-2-fluorophenol View Details
Isopropyl 2-(3-Nitrobenzylidene)acetoacetate View Details
2,6-Dioxopiperidine-3-ammonium chloride View Details
2-Chloro-3-iodopyridine manufacturer 1,3-Diiodopropane manufacturer 2,6-Dichloro-3-fluoroacetophenone manufacturer N-benzyl-6-(4-phenylbutoxy)hexan-1-amine manufacturer 1-Chloro-6-fluorohexane manufacturer